Zhejiang Xianju Pharmaceutical Co.,Ltd.

Shenzhen Stock Exchange 002332.SZ

Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending December 31, 2023: USD 0.59

Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue Per Share is USD 0.59 for the year ending December 31, 2023, a -8.37% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 0.64, a -7.02% change year over year.
Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.69, a 10.86% change year over year.
Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.62, a 7.08% change year over year.
Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.58, a 0.80% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shenzhen Stock Exchange: 002332.SZ

Zhejiang Xianju Pharmaceutical Co.,Ltd.

CEO	Mr. Weihua Jin
IPO Date	Jan. 12, 2010
Location	China
Headquarters	No. 1 Xianyao Road
Employees	3,281
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers active pharmaceutical ingredients, such as steroid drugs, and male and female hormones; intermediates; and finished formulations in the form of tablets, capsules, granules, soft capsules, powder inhalations, creams, gels, injections, and powder-injections. Zhejiang Xianju Pharmaceutical Co.,Ltd. was founded in 1972 and is based in Xianju, China.

Key trends

Past 5 years